We have previously shown that UBE4B gene expression is strongly associated with neuroblastoma patient outcomes, prognostic features, and tumor differentiation [37, 38], and we hypothesized that UBE4B would interact with members of DNA damage and repair and apoptotic pathways, potentially mediating the observed associations between UBE4B expression and patient outcomes. Here, UBE4B is linked to neuroblastoma.